Hesham Elghazaly: The ground-breaking scientific agenda of BGICC
Hesham ElGhazaly, CEO of Alfa Cure Oncology Center, shared a post on Facebook:
“The release of the most comprehensive ground-breaking scientific agenda of the iconic multidisciplinary oncology conference in the Middle East and Africa…
All the world leaders and the international regional and local organizations who are interested in womens health and Breast and Gynecological Cancer will be in Cairo Egypt next Thursday 23rd of January 8 Am starting with more than 150 international experts and more than 3000 participants registered… waiting to see you in this Oncolgy Festival.
The link of the full agenda to download.
Share to all the scientific community interested in women’s health…”
More posts featuring BGICC 2025.
Hesham ElGhazaly is a Professor of Clinical Oncology at Ain Shams University and the Founder and CEO of Alfa Cure Oncology Center. He serves as President of the Executive Board of the Egyptian Cancer Society and BGICS (Breast-Gynecological International Cancer Society).
Dr. ElGhazaly is a member of the IARC Scientific Committee (IARC/WHO), leads the Presidential Initiative for Women’s Health under Egypt’s Ministry of Health and Population, and heads MASRI (Middle East for Advanced Scientific Research and Innovation) at Ain Shams University. He also serves on the Board of Directors at ABC Global Alliance.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023